Browse Category

Stock Forecasts News 10 December 2025 - 15 December 2025

cbdMD (YCBD) Stock News Today (Dec. 15, 2025): Why Shares Are Volatile, What the Latest Filings Say, and the Updated YCBD Stock Forecast

cbdMD (YCBD) Stock News Today (Dec. 15, 2025): Why Shares Are Volatile, What the Latest Filings Say, and the Updated YCBD Stock Forecast

December 15, 2025 — cbdMD, Inc. (NYSE American: YCBD) is back on traders’ radars after a sharp, high-volume move that has turned this micro-cap wellness name into one of the most talked-about tickers in the hemp and cannabis-adjacent space this week. The rally is being fueled by a mix of company-specific catalysts (exchange compliance + preliminary FY2025 results) and sector-wide momentum tied to Washington policy headlines. PR Newswire+2PR Newswire+2 Below is a full roundup of the latest cbdMD stock news, key SEC details, what management has already guided for fiscal 2025, and where the current YCBD stock forecast stands as
BigBear.ai (BBAI) Stock: News, Catalysts, Forecasts, and Risks to Watch Before the Market Opens (Dec. 15, 2025)

BigBear.ai (BBAI) Stock: News, Catalysts, Forecasts, and Risks to Watch Before the Market Opens (Dec. 15, 2025)

BigBear.ai Holdings, Inc. (NYSE: BBAI) heads into the Monday, December 15, 2025 U.S. session with two narratives tugging the stock in opposite directions: a defense-focused AI growth story (including a high-profile generative AI acquisition) and investor concerns around contract timing, profitability, and potential dilution. As of the most recent trading data available ahead of Monday’s open, BBAI last traded around $6.38, down roughly $0.37 (about 5.4%), on exceptionally heavy volume. Below is what market participants are likely to focus on before the bell. Key takeaways for Monday’s pre-market watchlist What BigBear.ai does and why the market cares BigBear.ai sells “mission-ready”
Intuitive Surgical (ISRG) stock: What to know before the U.S. market opens on Dec. 15, 2025

Intuitive Surgical (ISRG) stock: What to know before the U.S. market opens on Dec. 15, 2025

As U.S. markets head into Monday’s open (Dec. 15, 2025), Intuitive Surgical, Inc. (NASDAQ: ISRG) is back in focus after a busy stretch of headlines spanning new FDA clearances, competitive pressure rising, and fresh Wall Street calls. Shares most recently traded around $542.32 (based on the latest available pricing ahead of Monday’s session). Below is what investors and watchlists are likely keying on before the opening bell. 1) The newest catalyst: FDA expands da Vinci SP indications (Dec. 10) Intuitive’s most recent company-driven headline is a new U.S. FDA clearance for its da Vinci Single Port (SP) system—expanding indicated use
Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (NASDAQ: FOLD) is near a 52-week high after strong results and bullish analyst coverage. Here’s the latest news, forecasts, catalysts, and key risks as of Dec. 14, 2025. As of Sunday, December 14, 2025 (with U.S. markets closed), Amicus Therapeutics, Inc. (NASDAQ: FOLD) is finishing the week in the spotlight after a sharp move higher. The stock last traded around $10.55 on Friday, December 12, after climbing roughly 6.6% on the session and touching an intraday high of $10.85—a level that also marks the top end of its $5.51–$10.85 52‑week range. Yahoo Finance The late-week push has also
Marvell Technology Stock (MRVL) News, Forecasts and Analysis for Dec. 14, 2025: Celestial AI Deal, Hyperscaler Rumors, and Wall Street Price Targets

Marvell Technology Stock (MRVL) News, Forecasts and Analysis for Dec. 14, 2025: Celestial AI Deal, Hyperscaler Rumors, and Wall Street Price Targets

(SEO): Marvell Technology (NASDAQ: MRVL) stock has been volatile after record Q3 FY2026 results, the $3.25B Celestial AI acquisition, and reports involving Microsoft and Amazon custom-chip programs. Here’s the latest news, analyst forecasts, and what investors are watching next (as of Dec. 14, 2025). MarketBeat+3Marvell Technology, Inc.+3Reuters+3 Marvell Technology, Inc. (NASDAQ: MRVL) is ending the week in the spotlight—and not just because the semiconductor sector has been choppy. The stock closed Dec. 12 at about $84.43, down ~5.6% on the day after a sharp, rumor-driven swing earlier in the week, then moved modestly in after-hours trading. Investing.com+1 Behind the volatility
Intel Stock (INTC) Today: Key Headlines, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 14, 2025

Intel Stock (INTC) Today: Key Headlines, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 14, 2025

Intel (NASDAQ: INTC) stock ended the week lower after a sharp pullback from recent highs. Here’s the latest news, analyst forecasts, and the catalysts investors are watching as of Dec. 14, 2025. Dateline: December 14, 2025 Intel Corporation (NASDAQ: INTC) stock heads into the week of December 15 with investors weighing a fresh batch of governance questions, geopolitical scrutiny around chipmaking tools, and renewed deal chatter—against the backdrop of Intel’s still-unfolding turnaround under CEO Lip-Bu Tan and a market that has turned more selective about “AI” narratives. With U.S. markets closed on Sunday, Intel shares are effectively “as of Friday’s
Johnson & Johnson (JNJ) Stock News Today, Forecasts and Analyst Targets (Dec. 12, 2025)

Johnson & Johnson (JNJ) Stock News Today, Forecasts and Analyst Targets (Dec. 12, 2025)

Published: December 12, 2025 Johnson & Johnson stock (NYSE: JNJ) is ending the week in the spotlight as shares hover near record territory, helped by a steady stream of analyst target updates, fresh late-stage clinical data disclosures, and a clearer roadmap for portfolio reshaping heading into 2026. As of 14:33 UTC on Dec. 12, 2025, JNJ shares traded at $210.50, up 0.23% on the day, after opening near $210.89 and trading between $208.50 and $210.89. JNJ stock price today: near a record after Thursday’s all-time high close JNJ is coming off a notable milestone: Yahoo Finance historical data shows JNJ
Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

December 12, 2025 — Cronos Group Inc. (NASDAQ: CRON , TSX: CRON ) is back in the spotlight after cannabis stocks jumped broadly into early trading on reports that the Trump administration could pursue a major easing of federal marijuana restrictions — specifically, a push to reclassify marijuana from Schedule I to Schedule III .Reuters+ 1 For Cronos investors, today’s move is not happening in a vacuum. The stock entered December with fresh momentum after the company announced a strategic acquisition in the Netherlands , a deal that management says would give Cronos the #1 market share within Europe’s largest
Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)

Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)

Dec. 12, 2025 — Aurora Cannabis Inc. stock (NASDAQ: ACB; TSX: ACB) is in focus Friday as cannabis equities broadly rally on fresh reporting that President Donald Trump is considering steps to loosen federal marijuana restrictions, including directing agencies toward reclassifying marijuana as a Schedule III drug .Reuters+ 1 In pre-market trading, Aurora Cannabis (ACB) rose about 15% alongside other cannabis names, reflecting how quickly US federal policy headlines can re-rate sentiment across the sector—even for Canada-based operators with international medical exposure.Investing.com+ 1 What’s driving Aurora Cannabis stock today 1) Cannabis stocks surge after Schedule III reporting The day’s main
Hut 8 Corp (HUT) Stock on December 11, 2025: Price, News, Analyst Ratings and 2026 Forecast

Hut 8 Corp (HUT) Stock on December 11, 2025: Price, News, Analyst Ratings and 2026 Forecast

Updated December 11, 2025 Hut 8 stock today: volatile trading near the top of its 52‑week range Hut 8 Corp (Nasdaq, TSX: HUT) – the energy‑infrastructure and Bitcoin mining company – is trading around the mid‑$40s on December 11, 2025. Real‑time data shows the shares near $45.30, with an intraday range between $42.84 and $45.30, down about 1.6% on the day in U.S. trading. Over the last twelve months, Hut 8 has swung between roughly $10.04 at the low and $57.29 at the high, giving it a market capitalization of about $4.85 billion. The stock currently carries a negative price‑to‑earnings
Coinbase (COIN) Stock on December 10, 2025: Price, Latest News, Forecasts and What It Means for Investors

Coinbase (COIN) Stock on December 10, 2025: Price, Latest News, Forecasts and What It Means for Investors

Note: This article is for informational purposes only and does not constitute financial or investment advice. Always do your own research or consult a licensed adviser. Quick Snapshot of Coinbase Stock Today As of late morning on December 10, 2025, Coinbase Global, Inc. (NASDAQ: COIN) is trading around $275–276 per share, down modestly on the day. That puts its market capitalization near $74 billion, with: StockAnalysis After surging to around $353 on October 24 following a JPMorgan upgrade to “Overweight” with a $404 target, COIN has since dropped roughly 21–22%, tracking a sharp pullback in crypto prices. AInvest Over the
Tesla Stock (TSLA) on December 10, 2025: Price Action, China Rebound, Model Y Incentives and Wall Street Forecasts to 2030

Tesla Stock (TSLA) on December 10, 2025: Price Action, China Rebound, Model Y Incentives and Wall Street Forecasts to 2030

As of Wednesday, December 10, 2025, Tesla, Inc. (NASDAQ: TSLA) is trading near the mid‑$440s after closing at $445.17 on Tuesday, up 1.27% on the day. Over the past year the stock has swung between roughly $214 and $489, leaving shares closer to the top of their 52‑week range. Investing.com+1 Investors are juggling an unusually dense set of catalysts: record Q3 deliveries and energy deployments, a rebound in China, aggressive year‑end incentives on the Model Y and Model 3, and sharply diverging analyst calls that value Tesla either as an expensive automaker or a long‑duration AI and robotics play. Below

Stock Market Today

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Go toTop